Avantor, Inc. (NYSE:AVTR) Shares Sold by Swedbank AB

Swedbank AB cut its stake in shares of Avantor, Inc. (NYSE:AVTRFree Report) by 2.0% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 104,998 shares of the company’s stock after selling 2,184 shares during the period. Swedbank AB’s holdings in Avantor were worth $2,716,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in AVTR. 1832 Asset Management L.P. grew its stake in shares of Avantor by 1,634.9% in the 2nd quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock valued at $180,839,000 after buying an additional 8,038,451 shares during the period. CCLA Investment Management grew its holdings in shares of Avantor by 147,220.3% during the first quarter. CCLA Investment Management now owns 4,720,144 shares of the company’s stock worth $120,828,000 after purchasing an additional 4,716,940 shares during the last quarter. Sound Shore Management Inc. CT acquired a new position in Avantor in the second quarter valued at $76,412,000. Canada Pension Plan Investment Board lifted its holdings in shares of Avantor by 6.8% during the second quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company’s stock worth $486,059,000 after purchasing an additional 1,463,695 shares during the period. Finally, Magnetar Financial LLC acquired a new position in Avantor during the 1st quarter worth approximately $35,154,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Price Performance

NYSE:AVTR opened at $24.72 on Friday. Avantor, Inc. has a 52 week low of $16.63 and a 52 week high of $28.00. The company has a market capitalization of $16.79 billion, a price-to-earnings ratio of 63.38, a PEG ratio of 2.93 and a beta of 1.33. The company has a 50-day moving average of $25.65 and a 200-day moving average of $24.34. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.05 and a current ratio of 1.59.

Avantor (NYSE:AVTRGet Free Report) last released its quarterly earnings results on Friday, July 26th. The company reported $0.25 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.02. Avantor had a return on equity of 12.40% and a net margin of 5.28%. The business had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.70 billion. As a group, equities research analysts anticipate that Avantor, Inc. will post 1.01 earnings per share for the current fiscal year.

Insider Activity

In other news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the sale, the chief accounting officer now directly owns 29,544 shares of the company’s stock, valued at $740,372.64. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 1.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on AVTR. Barclays upped their target price on Avantor from $25.00 to $28.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Royal Bank of Canada restated an “outperform” rating and set a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. Stifel Nicolaus increased their price target on Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a report on Monday, July 29th. TD Cowen boosted their target price on shares of Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Finally, Citigroup cut Avantor from a “buy” rating to a “neutral” rating and cut their price target for the stock from $30.00 to $23.00 in a research note on Wednesday, July 10th. Three equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, Avantor has an average rating of “Moderate Buy” and a consensus price target of $28.00.

Check Out Our Latest Research Report on AVTR

Avantor Profile

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Stories

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRFree Report).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.